{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:17:23Z","timestamp":1789903043861,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.diagmicrobio.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T14:08:55Z","timestamp":1521382135000},"page":"260-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Can anti\u2013PGL-1 and anti\u2013NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?"],"prefix":"10.1016","volume":"91","author":[{"given":"Amanda Carreira","family":"Devides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Sammarco","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"de Faria Fernandes Belone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neusa Maria Broch","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somei","family":"Ura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane Aparecida","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1590\/0074-0276130222","article-title":"Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy","volume":"108","author":"Antunes","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"Supl. 2","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1590\/S0037-86822008000700014","article-title":"Associa\u00e7\u00e3o entre rea\u00e7\u00e3o hans\u00eanica ap\u00f3s alta e a carga bacilar avaliada utilizando sorologia anti PGL-I e baciloscopia","volume":"41","author":"Brito","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.diagmicrobio.2018.03.002_bb0015","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1128\/JCM.41.5.1991-1995.2003","article-title":"Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy","volume":"41","author":"Buhrer-Sekula","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/JCM.02085-13","article-title":"Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy","volume":"52","author":"Duthie","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2018.03.002_bb0025","series-title":"Leprosy","first-page":"87","article-title":"Overview of host\u2013parasite relations","author":"Harboe","year":"1994"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0005396","article-title":"Leprosy reactions: the predictive value of Mycobacterium leprae\u2013specific serology evaluated in a Brazilian cohort of leprosypatients (U-MDT\/CT-BR)","volume":"11","author":"Hungria","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.diagmicrobio.2018.03.002_bb0035","first-page":"9","article-title":"Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation?","volume":"65","author":"Lienhardt","year":"1994","journal-title":"Lepr Rev"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0040","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1590\/0074-02760150198","article-title":"Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1\/LID-1: higher susceptibility to develop type 2 reactions","volume":"110","author":"Mizoguti Dde","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0045","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/1523-1747.ep12381958","article-title":"Th1-Th2 paradigm: insights from leprosy","volume":"102","author":"Modlin","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"Suppl. 2","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/S0037-86822008000700004","article-title":"Leprosy serology using PGL-I: a systematic review","volume":"41","author":"Moura","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.diagmicrobio.2018.03.002_bb0055","first-page":"80","article-title":"Leprosy reactions: new knowledge","volume":"46","author":"Naafs","year":"1994","journal-title":"Trop Geogr Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0060","first-page":"97","article-title":"Current views on reactions in leprosy","volume":"72","author":"Naafs","year":"2000","journal-title":"Indian J Lepr"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0065","first-page":"263","article-title":"Leprosy control through multidrug therapy (MDT)","volume":"69","author":"Noordeen","year":"1991","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.diagmicrobio.2018.03.002_bb0070","series-title":"Leprosy","first-page":"237","article-title":"Clinical leprosy","author":"Pfaltzgraff","year":"1994"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0075","first-page":"255","article-title":"Classification of leprosy according immunity \u2014 a five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.diagmicrobio.2018.03.002_bb0080","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0140-6736(91)91232-J","article-title":"Risk factors for type-1 reactions in borderline leprosy patients","volume":"338","author":"Roche","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2018.03.002_bb0085","first-page":"35","article-title":"Serological monitoring of the response to chemotherapy in leprosy patients","volume":"61","author":"Roche","year":"1993","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2018.03.002_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/trstmh\/trx026","article-title":"Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis","volume":"111","author":"Serrano-Colla","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.diagmicrobio.2018.03.002_bb0100","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1365-3156.2007.01951.x","article-title":"Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multidrug treatment and reactions","volume":"12","author":"Silva","year":"2007","journal-title":"Tropical Med Int Health"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.47276\/lr.88.2.174","article-title":"Serodiagnosis of leprosy and follow-up of household contacts using a commercial rapid test containing ND-O\/LID-1 antigens","volume":"88","author":"Silva","year":"2017","journal-title":"Lepr Rev"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.03.002_bb0110","first-page":"356","article-title":"Assessment of anti-PGL-I as a prognostic marker of leprosy reaction","volume":"66","author":"Stefani","year":"1998","journal-title":"Int J Lepr Other Mycobact Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318300804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318300804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T12:22:57Z","timestamp":1603974177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318300804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0732889318300804"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.03.002","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can anti\u2013PGL-1 and anti\u2013NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}